08.25.26 -- Reimagine Solid Tumor Immunotherapy With SRC-3-Edited Tregs

Learn how life sciences innovators use industrial data fabrics to eliminate manual tech transfer errors, bridge departmental silos, and accelerate time-to-market.

Sterile connectors streamline cell and gene therapy processes while maintaining sterility. By withstanding extreme temperatures and cryoprotectants, they can ensure product viability during cryopreservation.

Optimize upstream bioprocessing from cell line development to commercial production. Leverage predictive data modeling and modular bioreactor systems for seamless scale-up.

Automated fill-finish systems protect sensitive cell therapies using low-shear handling to maintain dose uniformity, cell viability, and process consistency across every batch.

mRNA poly(A) tail analysis depends on targeted digestion, clean LC/MS conditions, and reliable deconvolution. See how RNase 4 digestion and optimized ion-pairing methods support reproducible results.

Freezing and ultra-cold storage are often planned in isolation, but treating them as a single integrated system can reveal overlooked facility design opportunities.

Smarter viral vector manufacturing starts with early alignment, realistic scaling, and collaboration. Strategy and transparency reduce risk, control costs, and keep timelines on patients.

Grasp how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications.

Streamline viral vector manufacturing with perfusion technologies that reduce costs and improve scalability. Discover how a tangential flow depth filtration system enhances yield and quality.

From donor variability to collection site inconsistencies, cell and gene therapy faces raw material challenges. Ensuring stable, high-quality leukopaks is vital for effective treatments.

Explore how T cell–depleted haplo-HSCT is expanding donor options for pediatric patients, with insights into clinical outcomes, immune recovery, and evolving strategies.

Gain insights from two cases where clients overcame obstacles during virus bank manufacturing, from the technical transfer to the preparation of materials and documentation for the GMP campaign.